The scandal of poor epidemiological research: ***
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
has to be reconsidered.Thirdly, we must find ways of preventing further similar episodes (box).Single phase III drug trials are simply not big enough to detect relatively uncommon but important adverse events, which may affect large numbers of people in routine clinical use.6 The potential public health impact of previously undetected drug related adverse events is likely to be made worse if widely marketed new drugs are prescribed haphazardly and rapidly to large numbers of people.Within five months of the launch of rofecoxib, more than 42 000 patients had been prescribed the drug in England, 11 even though newly marketed drugs carry a black triangle warning, indicating an incomplete safety profile.Unfortunately, postmarketing surveillance is not a panacea to determine safety, as methodological flaws may produce inaccurate results.We therefore recommend that drug companies are legally required to make all data on serious adverse events from clinical studies available to the public immediately after completion of the research.This will allow independent, timely, and updated systematic reviews of serious adverse events.In addition, we advocate the phased introduction of new interventions through randomised trials, which are independent from the pharmaceutical industry and are large enough to study rare outcomes, together with systematic, more robust, and comprehensive approaches to pharma-covigilance.12 Although these measures will not be popular with pharmaceutical companies, they will limit the numbers of patients exposed unsystematically to unknown hazards and provide robust and unbiased evidence on adverse events before a drug is licensed fully.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Self-citationMoher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Moher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
The scandal of poor medical research.
Altman, D. G. (1994) · BMJ · doi:10.1136/bmj.308.6924.283 · Cited by 897
Lawlor, D. A., Smith, G. D., Bruckdorfer, K. R., Kundu, D., & Ebrahim, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16260-0 · Cited by 438
Issues in the reporting of epidemiological studies: a survey of recent practice.
Pocock, S. J., Collier, T. J., Dandreo, K. J., de Stavola, B. L., Goldman, M. B., Kalish, L. A., Kasten, L. E., & McCormack, V. A. (2004) · BMJ · doi:10.1136/bmj.38250.571088.55 · Cited by 313
Cited by
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies
Chen, H., Cohen, P., & Chen, S. (2010) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610911003650383 · Cited by 1,952
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Just one question: If one question works, why ask several?
Bowling, A. (2005) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2004.021204 · Cited by 864
Metadata
- Authors
- Elm, E. V., & Egger, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2004-10-14
- Volume
- 329
- Issue
- 7471
- Pages
- 868-869
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2144274361
- Cited by
- 134
- References
- 11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The scandal of poor epidemiological research: ***. https://app.cochat.ai/papers/10.1136/bmj.329.7471.868
- The paper
- Elm, E. V., & Egger, M. (2004). The scandal of poor epidemiological research: ***. BMJ. https://doi.org/10.1136/bmj.329.7471.868
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.